AzTrials
AzTrials

Sarcopenia in ElderlyPrevHAD RCTNCT07373587

Preventing Hospital Associated Disability in Older Patients: Individualized Nutrition and Exercise Strategy

A study testing Exercise in people with Sarcopenia in Elderly and Hospital Associated Disability, run by Bispebjerg Hospital at 1 site in Denmark.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Aproximately a third of persons older than 70 years lose physical function and ability to take care of themselves during a stay at a hospital. This is associated to an increased risk of readmission and mortality. Read more about this study

Who is it for?
Ages 65 years and older
What is being tested?
Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
360 participants
Where
1 siteDenmark
Study dates
3 Feb 2026to 29 Sep 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Hospitalized at the geriatric ward
  • Speak Danish or English
  • Ability to give informed consent

Who cannot join

  • Moderate to severe Dementia
  • Manifest delirium

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Kristian V Lolck, MD, Ph.d. student contact

+4560612914

kristian.kaltoft.lolck@regionh.dk

Charlotte Suetta, professor contact

charlotte.suetta@regionh.dk

Denmark1 site, 1 recruiting
  • Bispebjerg Hospital

    Copenhagen, Capital Region, 2400

    Kristian V Lolck, MD, ph.d. student, +4560612914, kristian.kaltoft.lolck@regionh.dk

    Charlotte Suetta, Professor, charlotte.suetta@regionh.dk

    Recruiting

Other trials in Denmark

About this study

Official title: Preventing Hospital Associated Disability in Older Patients: Individualized Nutrition and Exercise Strategy, a Randomized Controlled Trial

Aproximately a third of persons older than 70 years lose physical function and ability to take care of themselves during a stay at a hospital. This is associated to an increased risk of readmission and mortality. Earlier research has shown that insufficient nutrition and physical activity during hospital stay, leading to a loss in muscle mass and strength, plays an important role in this fall in functionality. This study aims to examine if a structured and supervised resistance and mobility exercise intervention, can prevent this fall in functional ability during hospital stay among older patients. The Impact of nutritional status will be investigated by registrering caloric, protein and hydtrational intake during the study period.

Read the detailed description

Older persons are highly susceptible to hospital associated disability (HAD), defined by a loss of physical function during hospitalization, leading to increased dependency, morbidity, and mortality. Key factors in developing HAD are physical inactivity, malnutrition and dehydration, leading to a decline in muscle mass and muscle strength. Therefore, there is a need to develop effective nutritional and exercise interventions for older patients, during hospitalization. Hypothesis: This study expects that a mobility-graded individualized exercise intervention will effectively prevent a decline in activities of daily living (ADL) function, mobility level, physical function, muscle and strength, and reduce the length of stay, risk of re-admission and mortality among older patients during hospital stay. The investigators furthermore hypothesize that sufficcient nutrition and hydration will improve the impact of the exercise intervention. The study is designed as a randomized controlled trial, and will include 360 participants, men and women, ≥ 65 years old from the geriatric care unit of Bispebjerg Hospital, Denmark. After inclusion, participants will have estimated nutritional status, frailty and mobility, muscle mass and strength, physical function, ADL function, cognitive function and quality of life. Futhermore, blood samples for analysis of anabolic and inflammatory biomarkers as well as microbiome samples will be taken at baseline testing. After baseline testing, the participants will be divided randomely 1:1 into a control group and an intervention group. All participants will have nutritional and hydrational intake registered and wear accelerometers during the study period. The participants in the intervention group will receive 2 x 30 minutes supervised exercise (resistance and mobility) every day during the stury period. At discharge or transfer from the geriatric care unit, participants will be tested for mobility, muscle mass and strength, physical function, ADL function, cognitive function and quality of life. 1 Month after discharge from hospital, the participants will recieve af telefon interview, reporting on ADL-function, mobility, quality of life and nutritional status. Participants succesfully reached by telephone interview, will be asked further permission for a homevisit, where muscle strength and mass, physical function, mobility, cognitive function and ADL function will be evaluated.

Being tested
Exercise
Keywords
Older, Hospitalized, Sarcopenia, Malnutrition, Exercise intervention
Medical subject headings
Sarcopenia, Malnutrition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ExerciseOther

    Also called Training, Physiotheraphy

    The participants in the intervention group will recieve supervised exercise two times 30 minutes each day during hospitalization. The first exercise pass consists of resistance exercise, and can be performed supine in bed, sitting on the edge of the bed, and in a close-by exercise area, based on participants mobility level. The second exercise pass consists of mobility exercise, aiming to transfer the participant from supine in the bed to sitting position, transfer to chair, walking with or without walking aids or walking on stairs.

Study groups in NCT07373587
Study groupRoleWhat they receive
ControlNo interventionThe control group will recieve usual care at the geriatric care unit, with mobility exercise performed based on individual preferences and ability, performed by regular care personelle and regular physiotherapy staff.
Exercise interventionExperimentalThe exercise intervention group will recieve two times 30 minutes of supervised exercise (mobility and resistance exercise) every day during their stay at the geriatrich care unit.
Receives: Other: Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in activities of daily living (ADL) function, by Barthel index-100

    describes the level of independence in activities of daily living, score of 0 equals total dependence and a score of 100 equals total independence

    Measured: From enrollment to discharge/transfer from the geriatric care unit (aproximately 5 days), measured again 1 month after discharge.

Secondary outcomes (14)
  1. Changes in mobility by Cumulated Ambulation Score

    Cumulated Ambulation Score (assesed mobility, 0 (lowest)-6(highest))

    Measured: From enrollment to discharge/transfer from the geriatric care unit (aproximately 5 days), measured again 1 month after discharge

  2. Changes in Knee extension strength,

    (Knee extension strength, maximal voluntary contraction, newton meter)

    Measured: From enrollment to discharge/transfer from the geriatric care unit (aproximately 5 days), measured again 1 month after discharge.

  3. Changes in Hand Grip Strength

    Hand grip strength, kilogram

    Measured: From enrollment to discharge/transfer from the geriatric care unit (aproximately 5 days), measured again 1 month after discharge.

  4. Changes in Sit-to-stand performance

    Sit-to-stand test, number of repetitions in 30 seconds, continous scale

    Measured: From enrollment to discharge/transfer from the geriatric care unit (aproximately 5 days), measured again 1 month after discharge.

  5. Changes in Gait speed

    Gait speed, velocity (meters/seconds)

    Measured: From enrollment to discharge/transfer from the geriatric care unit (aproximately 5 days), measured again 1 month after discharge.

  6. Changes in Quadriceps muscle thickness

    Quadriceps muscle thickness, ultrasound, millimeters

    Measured: From enrollment to discharge/transfer from the geriatric care unit (aproximately 5 days), measured again 1 month after discharge.

  7. Changes in muscle mass

    muscle mass, bioimpedance analysis, kilogram

    Measured: From enrollment to discharge/transfer from the geriatric care unit (aproximately 5 days), measured again 1 month after discharge.

  8. Changes in appetite

    appetite, simplified nutritional appettite questionaire. Scale, 4-20, lower values indicates higher risk of insufficient nutritional intake

    Measured: From enrollment to discharge/transfer from the geriatric care unit (aproximately 5 days), measured again 1 month after discharge.

  9. Changes in quality of life

    quality of life, EuroQol- 5Dimensions-5 levels, questionaire, scale from 1-5 i each of five dimensions, higher scores indicates lower quality of life

    Measured: From enrollment to discharge/transfer from the geriatric care unit (aproximately 5 days), measured again 1 month after discharge.

  10. Readmission 30 days from discharge

    Participants readmitted to the hospital within 30 days of discharge, categorical yes or no

    Measured: From inclusion to 30 days after discharge from hospital

  11. Mortality 30 days, 90 days and 1 year after discharge

    Participant diseased at 30 days, 90 days or 1 year after discharge from hospital, categorical, yes/no

    Measured: From inclusion to 1 year after discharge from hospital

  12. Changes in municipal care needs at discharge, 1 month and 3 months after discharge

    Need for municipal care services, number of weekly visits, minutes of care service

    Measured: Retrospectively 14 days berfore inclusion to 3 months after discharge from hospital

  13. Discharge destination

    Discharged to own home, temporary rehabillitation or permanent care facility, categorical, yes or no

    Measured: From inclusion to discharge from hospital (aproximately 5 days after inclusion)

  14. Physical activity during hospitalization

    Steps taken and time upright, accelerometer

    Measured: From inclusion to discharge from hospital (aproximately 5 days after inclusion)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jan 2026
  2. Study start3 Feb 2026
  3. Primary completion28 Sep 2027 (estimated)
  4. Study completion29 Sep 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
360 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07373587
Sponsor's protocol ID
p-2026-20660
Other IDs
3165-00244B
Acronym
PrevHAD RCT
Status last verified
Sep 2026
First submitted
20 Jan 2026
Last updated
30 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: We will share the protocol for the exercise intervention, as well as participants charecteristics and outcome data, in a data repository, when the data can be fully anonymized

Questions about this trial

What is this clinical trial studying?

A study testing Exercise in people with Sarcopenia in Elderly and Hospital Associated Disability, run by Bispebjerg Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Kristian V Lolck, MD, Ph.d. student (+4560612914, kristian.kaltoft.lolck@regionh.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in activities of daily living (ADL) function, by Barthel index-100 (time frame: From enrollment to discharge/transfer from the geriatric care unit (aproximately 5 days), measured again 1 month after discharge.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in